Home LiteratureArticle Details
PMID: 11897284 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis.

Lancet (London, England) ·Vol. 359 ·No. 9309 ·2002-03-09 ·Pages 841-7

Arca M, Zuliani G, Wilund K, Campagna F, Fellin R, Bertolini S, Calandra S, Ricci G, Glorioso N, Maioli M, Pintus P, Carru C, Cossu F, Cohen J, Hobbs HH

Abstract

Autosomal recessive hypercholesterolaemia (ARH) is caused by mutations in a putative adaptor protein called ARH. This recessive disorder, characterised by severe hypercholesterolaemia, xanthomatosis, and premature coronary artery disease, is rare except on the island of Sardinia, Italy. Our aim was to ascertain why ARH is more common on Sardinia than elsewhere. We obtained detailed medical histories, did physical examinations, measured concentrations of lipoproteins, and harvested genomic DNA from 28 Sardinians with ARH from 17 unrelated families. We sequenced the coding regions and consensus splice sites of ARH in probands from these families, and from 40 individuals of non-Sardinian origin who had an autosomal recessive form of hypercholesterolaemia of unknown cause. Two ARH mutations, a frameshift mutation (c432insA) in exon 4 (ARH1) and a nonsense mutation (c65G-->A) in exon 1 (ARH2), were present in all of the 17 unrelated families with ARH. Three of the ARH alleles contained both mutations, as a result of an ancient recombination between ARH1 and ARH2. No regional clustering of the three mutant alleles within Sardinia was apparent. Furthermore, four Italians from the mainland with autosomal recessive hypercholesterolaemia were homozygous for ARH1. The small number, high frequency, and dispersed distribution of ARH mutations on Sardinia are consistent with these mutations being ancient and maintained in the Sardinian population because of geographic isolation.

MeSH Terms
Adolescent Adult Child Female Haplotypes Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use Hypercholesterolemia/drug therapy,epidemiology,genetics Italy/epidemiology Male Middle Aged Molecular Biology Mutation
Chemicals
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Arca Marcello
Department of Medical Therapy, University of Rome La Sapienza, Italy.
Zuliani Giovanni
Wilund Kenneth
Campagna Filomena
Fellin Renato
Bertolini Stefano
Calandra Sebastiano
Ricci Giorgio
Glorioso Nicola
Maioli Mario
Pintus Paolo
Carru Ciriaco
Cossu Fausto
Cohen Jonathan
Hobbs Helen H
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
2002-03-09
Pages
841-7
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Grants
NHLBI NIH HHS · HL0360 · United States
NHLBI NIH HHS · HL20948 · United States
NHLBI NIH HHS · HL47619 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com